Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been newly diagnosed with a specific type of blood cancer called precursor B-cell acute lymphoblastic leukemia (ALL), and whose cancer does not have a genetic marker called the Philadelphia chromosome
- People aged 15 to 59 years old
- People whose general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scoring system (called ECOG score 0–2)
- People whose doctors expect them to survive for at least 2 months
- People whose organs (such as heart, liver, and kidneys) are functioning well enough not to interfere with the treatments used in this trial
- People who understand the study and are willing to sign a consent form agreeing to take part
- Men and women of childbearing potential, along with their partners, who are willing to use effective contraception throughout the treatment period and for at least 12 months after the last dose of the study drug
Who may not be able to join:
- People whose leukemia has spread to the central nervous system (brain and spinal cord)
- People with serious problems affecting the heart, lungs, liver, kidneys, or other organs — including but not limited to severe infections, uncontrolled diabetes, severe heart failure or chest pain, active tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), or bronchiectasis
- People whose heart pumping function (measured by an echo scan) is below 45%
- People who have had another type of cancer in the past 5 years, with the exception of certain localised thyroid cancers or skin cancers that have not spread
- People with certain abnormal blood test results indicating the liver or kidneys may not be functioning well enough (confirm with trial site for specific values)
- People known to have HIV infection
- People who have any other condition that the trial doctor believes would interfere with the study drug
- People who are unable to understand or follow the study procedures
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8657187236896
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete remission rate with negative minimal residual disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.